首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmaceutical development and technology

缩写:PHARM DEV TECHNOL

ISSN:1083-7450

e-ISSN:1097-9867

IF/分区:2.5/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1903
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Shahinaze A Fouad,Nada Abdelaziz,Mahmoud H Teaima et al. Shahinaze A Fouad et al.
Cilostazol (CTZ), is a BCS class II drug with limited bioavailability. In the current study, orally disintegrating tablets (ODTs) for buccal delivery of CTZ were prepared by two methods; lyophilization (Lyo-ODTs) and direct compression (DC-...
Ruba S Darweesh,Farah S AlQawasmi,Mai S Khanfar Ruba S Darweesh
Ezetimibe (EZT) is a class II drug of the Biopharmaceutics classification system (BCS), with limited aqueous solubility and high permeability. This study aims to enhance the solubility and oral bioavailability of EZT by developing EZT solid...
Mudassir Ansari,Yogesh A Kulkarni,Kavita Singh Mudassir Ansari
The existing study focuses on the development, optimization, and evaluation of sorafenib-loaded polymeric nanomicelles for posterior segment delivery in treating retinoblastoma. The formulation involved adjusting various process and product...
Jie Wang,Xuemei Gu,Xia Gao et al. Jie Wang et al.
In order to enhance the therapeutic value of curcumin in liver cancer treatment, glycyrrhetinic acid-modified pH-sensitive curcumin liposomes (GA-pH-Lip@Cur) was developed.GA-pH-Lip@Cur was prepared using a thin film dispersion ultrasonicat...
Si-Rui Liu,Wen Lin,Xiang-Yang Xie et al. Si-Rui Liu et al.
The aim of this study was to develop and evaluate an extended-release (ER) push-pull osmotic pump (PPOP) tablet for phencynonate HCl (PCN), which could release the drug at zero-order profile for a duration of 24 h. The core tablets were des...
Xie Jiayu,K E Li,Lusi Chen et al. Xie Jiayu et al.
Intravitreous long-acting drug delivery system offers an excellent alternative to multiple injections for the treatment of non-infectious uveitis (NIU). However, the adverse effects of non-biodegradable intravitreal implants of fluocinolone...
Gabrielle Silva de Campos Lazzarini,Guilherme Luíz Da Silva,Laís S Lacerda et al. Gabrielle Silva de Campos Lazzarini et al.
3D printing has been emerging as a transformative technology in pharmaceutical manufacturing, offering potential for personalized medicine and innovative dosage forms. It enables precise control over drug release profiles and dosage customi...
Aya E Radwan,Ebtessam A Essa,Engy Elekhnawy et al. Aya E Radwan et al.
Cinacalcet hydrochloride (HCl), a calcium-sensing receptor agonist used to treat hyperparathyroidism, suffers from poor solubility, reducing its bioavailability. Recently, cinacalcet HCl has been probed for repurposing as antibacterial agen...
Ravi Kumar Sah,Sajeev KumarB Ravi Kumar Sah
The exploration of novel carriers for cancer treatments is on the rise, as drugs are often hindered by ineffective delivery to the tumor site. In the present study, Mesoporous silica nano scaffolds were developed by novel heat assisted hydr...
Yosra Sr Elnaggar,Abdelrahaman Mm Othman,Ashraf Farahat et al. Yosra Sr Elnaggar et al.
Tear trough deformity (TTD) is a significant cosmetic concern, with current treatments relying primarily on invasive injectable fillers, which are costly and carry risks of complications. Despite the widespread use of hyaluronic acid (HA) i...